I am a physician with good insurance, but every year we have faced higher out-of-pocket cost for my son’s EpiPen.
North Carolina Attorney General Jeff Jackson reached an $11 million settlement with Mylan, now part of pharmaceutical company Viatris, regarding alleged overpayments for EpiPens, according to an April ...
Jonathan is the deputy corporate editor at The Wall Street Journal, helping manage a team of reporters and editors who cover industries ranging from autos and airlines to retailers, food makers and ...
It looks like people with allergies won’t be limited to EpiPens for long, a new epinephrine auto-injector will be hitting the shelves in 2017. There’s going to be a cheaper EpiPen alternative on the ...
Daisy-Daisy / Getty Images A potentially ground-breaking nose-spray version of the drug epinephrine will soon hit the market — an alternative to auto-injectors like EpiPen for people having serious ...
Pharma giant Mylan became ground zero for the debate over rising drug prices back in 2016. At issue for Mylan specifically was its EpiPen pricing. An EpiPen is a drug-delivery device used to treat ...
June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...
WASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA (SASY.PA), opens new tab to revive its antitrust lawsuit accusing rival pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results